Hydroxysafflor yellow A suppresses liver fibrosis induced by carbon tetrachloride with high-fat diet by regulating PPAR-γ/p38 MAPK signaling
Authors:
- C. Y. WangCWC. Y. Wang
- Z. LiuZLZ. Liu
- X. S. MaXMX. S. Ma
- Y. H. HeYHY. H. He
- S. S. ChenSCS. S. Chen
- X. Y. BaiXBX. Y. Bai
- 12 March 2014
- journal article
- Published by Taylor & Francis in Pharmaceutical Biology
- Vol. 52 (9) , 1085-1093
Abstract
One approach to protect against liver fibrosis is the use of herb-derived natural compounds, such as hydroxysafflor yellow A (HSYA). The antifibrosis effect of HYSA against liver fibrosis has been investigated; however, its mechanisms have not yet been entirely revealed. To study the protective effects of HSYA on liver fibrosis induced by carbon tetrachloride (CCl4) and a high-fat diet (HFD), and to determine the mechanism of action of HSYA. CCl4 and HFD were used to mimic liver fibrosis in rats, and serum biochemical indicators were determined. The antifibrosis effects of HSYA were evaluated and its mechanisms were investigated by histopathological analysis, immunohistochemical staining, enzyme-linked immunosorbent assays, real-time-PCR, and western blotting. HSYA reduced CCl4- and HFD-mediated liver fibrosis and ameliorated serum biochemical indicator, downregulated the expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) (0.31 ± 0.03 protein, 0.59 ± 0.02 mRNA) and transformin growth factor-β1 (TGF-β1) (0.81 ± 0.02 protein, 0.58 ± 0.04 mRNA), and upregulated the expression of peroxisome proliferator-activated receptor-γ (PPAR-γ) (1.57 ± 0.13 protein, 2.48 ± 0.19 mRNA) and matrix metallopeptidases-2 (MMP-2) (2.31 ± 0.16 protein, 2.79 ± 0.22 mRNA) (p < 0.01, versus model group). These effects were significantly attenuated by PPAR-γ antagonist GW9662 via blocking the phosphorylation of p38 MAPK. These data demonstrate a novel role for HSYA in inhibiting CCl4- and HFD-mediated liver fibrosis, and reveal that PPAR-γ and p38 MAPK signaling play pivotal roles in the prevention of liver fibrosis induced by CCl4 and HFD.Keywords
This publication has 41 references indexed in Scilit:
- Hepatoprotective activity of berberine is mediated by inhibition of TNF-α, COX-2, and iNOS expression in CCl4-intoxicated miceToxicology, 2011
- Selective p38α Inhibitors Clinically Evaluated for the Treatment of Chronic Inflammatory DisordersJournal of Medicinal Chemistry, 2009
- Therapeutic efficacy of Traditional Chinese Medicine 319 recipe on hepatic fibrosis induced by carbon tetrachloride in ratsJournal of Ethnopharmacology, 2009
- Isoprostanes and hepatic fibrosisMolecular Aspects of Medicine, 2008
- Protective effects of hydroxysafflor yellow A on acute and chronic congestive cardiac failure mediated by reducing ET-1, NOS and oxidative stress in rats RETRACTED ARTICLEJournal of Pharmacy and Pharmacology, 2008
- Matrix Metalloproteinase Gene Delivery for Liver FibrosisPharmaceutical Research, 2007
- Kupffer Cell Engulfment of Apoptotic Bodies Stimulates Death Ligand and Cytokine ExpressionHepatology, 2003
- Liver fibrosis – from bench to bedsideJournal of Hepatology, 2003
- Growth Regulation via p38 Mitogen-activated Protein Kinase in Developing LiverJournal of Biological Chemistry, 2000
- Serum Markers as Tools to Monitor Liver FibrosisDigestion, 1998